Immunovant, Inc.IMVTNASDAQ
LOADING
|||
Operating Income Contraction
Trending lower, below historical average, strong compound growth.
Left:
||||
Profit from core business operations before interest and taxes
Latest
$-438.15M
↓ 155% below average
Average (7y)
$-172.15M
Historical baseline
Range
High:$-450.00
Low:$-438.15M
CAGR
+18.1%
Consistent expansion
| Period | Value | Change |
|---|---|---|
| 2025 | $-438.15M | -62.2% |
| 2024 | $-270.21M | -29.7% |
| 2023 | $-208.28M | -33.5% |
| 2022 | $-156.03M | -44.3% |
| 2021 | $-108.12M | -81.2% |
| 2020 | $-59.68M | -13261677.8% |
| 2019 | $-450.00 | +100.0% |
| 2018 | $-136.74M | - |